Skip to main content
SpringerLink
Log in

Patient Adherence: Challenges, Myths, and Realities

  • Chapter
  • First Online:
The Diabetes Textbook

  • 1528 Accesses

Abstract

Lack of compliance or adherence to treatment is a huge worldwide problem, and its magnitude will increase with the ascent of the burden of chronic disease and its comorbidities. Lack of adherence erodes health outcomes and increases the costs of medical care; it is an important modifier of the effectiveness of health care, and it has been shown that improvements enhance patients’ safety and well-being. Adherence is the result of multiple factors, including health beliefs, personal models of disease, patients’ satisfaction with medical services, communication, and the quality of care received. The decisive role of patients as responsible for implementing treatment “in the real world” needs to be recognized, measured, and expected. Implementing effective adherence interventions will have a greater impact on the health of the population than modern medical therapies that many patients are unwilling to take or cannot afford. Traditional medical approaches need to change: patients need to receive support, not to be blamed for their shortcomings to achieve the expected clinical outcomes; they and their families are responsible for their self-care; their efforts are essential components for the success of diabetes care.

The missing link in the cycle of clinical drug development is Pharmionics, the study of what the patient does with the drug.

John Urquarth.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Fox R. Compliance, adherence, concordance. Circulation. 1998;97:127.

    Article  Google Scholar 

  2. Wild H. The economic rationale for adherence in the treatment of Type 2 diabetes mellitus. Am J Manag Care. 2012;18:S43–8.

    PubMed  Google Scholar 

  3. Vrijens B, De Geest S, Hughes DA, Przemyslaw K, Demonceau J, Ruppar T, et al. A new taxonomy for describing and defining adherence to medications. Br J Clin Pharmacol. 2012;73:691–705.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Osterberg L, Blashke T. Adherence to medication. N Engl J Med. 2005;353:487–97.

    Article  CAS  PubMed  Google Scholar 

  5. Dolan MP. Compliance becomes concordance. Making a change in terminology produce a change in behavior. BMJ. 1997;314:691.

    Google Scholar 

  6. Howie JGR. The consultation: a multi-purpose framework. In: Sheldon M, Brooke J, Rector A, editors. Decision making in general practice. London: The MacMillan Press Ltd; 1985.

    Google Scholar 

  7. Anderson RM, Robins LS. How do we know? Reflections of qualitative research in diabetes. Diabetes Care. 1998;21:1387–8.

    Article  CAS  PubMed  Google Scholar 

  8. Boudes P. Drug compliance in therapeutics trials: a review. Control Clin Trials. 1998;19:257–68.

    Article  CAS  PubMed  Google Scholar 

  9. Neiman AB, Ruppar MH, Garber L, Weidle PJ, Hong Y, George MG, et al. CDC grand rounds: improving medication adherence for chronic disease management – innovations and opportunities. MMWR. 2017;66:1248–51.

    PubMed  PubMed Central  Google Scholar 

  10. Haynes RB. Introduction. In: Haynes RB, et al., editors. Compliance with therapeutic regimes. Baltimore, MD: Johns Hopkins University Press; 1976.

    Google Scholar 

  11. Lerner BH. From careless consumptives to recalcitrant patients: the historical construction of noncompliance. Soc Sci Med. 1997;45:1423–31.

    Article  CAS  PubMed  Google Scholar 

  12. Mohler DN, Wallin DG, Dreyfus EG. Studies in the home treatment of streptococcal disease. I. Failure of patients to take penicillin by mouth as described. N Engl J Med. 1955;252:116–8.

    Article  Google Scholar 

  13. Mohler DN, Wallin DG, Dreyfus EG, Bakst HJ. Studies in the home treatment of streptococcal disease. II. A comparison of the efficacy of oral administration of penicillin and intramuscular injection of benzathine penicillin in the treatment of streptococcal pharyngitis. N Engl J Med. 1956;254:45–50.

    Article  CAS  PubMed  Google Scholar 

  14. Wood HF, Stollerman GH, Feinstein AR, Hirschfeld I, Rusoff JH, Taranta A, et al. A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. I. Streptococcal infections and recurrences of acute rheumatic fever in the first two years of the study. N Engl J Med. 1957;257:394–8.

    Article  CAS  PubMed  Google Scholar 

  15. Feinstein AR, Wood HF, Epstein JA, Taranta A, Simpson R, Tursky E. A controlled study of three methods of prophylaxis against streptococcal infection in a population of rheumatic children. II. Results of the first three years of the study, including methods for evaluating the maintenance of oral prophylaxis. N Engl J Med. 1959;260:697–702.

    Article  CAS  PubMed  Google Scholar 

  16. Dixon WM, Stradling P, Wooton IDP. Outpatient P.A.S. therapy. Lancet. 1957;2:871–2.

    Article  Google Scholar 

  17. Maddock RK. Patient cooperation in taking medicines. A study involving isoniazid and aminosalicylic acid. JAMA. 1967;199:137–40.

    Article  Google Scholar 

  18. Vere DW. Errors of complex prescribing. Lancet. 1957;1:370–3.

    Google Scholar 

  19. Parsons T. The social system. Glencoe IL: Free Press; 1951.

    Google Scholar 

  20. Freidson E. Patients’ views of medical practice. New York: Sage; 1961.

    Google Scholar 

  21. Mechanic D. The concept of illness behavior. J Chronic Dis. 1962;15:189–94.

    Article  CAS  PubMed  Google Scholar 

  22. Eichorn RL, Riedel DC, Morris WHM. Compliance to perceived therapeutic advice. In Proc Purdue Farm Cardiac Seminar, Lafayette, IN, Purdue Agricultural Station, 1959, p 65.

    Google Scholar 

  23. Johannsen WJ, Hellmuth GA, Sorauf T. On accepting medical recommendations. Experiences with patients in a cardiac classification unit. Arch Environ Health. 1966;12:63–9.

    Article  CAS  PubMed  Google Scholar 

  24. Caron HS, Roth HP. Patients’ cooperation with a medical regimen. Difficulties in identifying the noncooperator. JAMA. 1968;203:120–4.

    Article  Google Scholar 

  25. Porter AMW. Drug defaulting in a general practice. BMJ. 1969;1:218–22.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  26. Davis MS. Variations in patients’ compliance with doctors’ orders: analysis of congruence between survey responses and results of empirical investigations. J Med Educ. 1966;41:1037–48.

    CAS  PubMed  Google Scholar 

  27. Davis MS. Variations in patients’ compliance with doctors’ advice: an empirical analysis of patterns of communication. AJPH. 1968;58:274–88.

    CAS  Google Scholar 

  28. Francis V, Korsch BM, Morris MJ. Gaps in doctor–patient communication. Patients’ response to medical advice. N Engl J Med. 1969;280:535–40.

    Article  CAS  PubMed  Google Scholar 

  29. La Greca AM. Issues in adherence with pediatric regimens. J Pediatr Psychol. 1990;15:423–36.

    Article  PubMed  Google Scholar 

  30. Kellaway GS, McCrae E. Non-compliance and errors of drug administration in patients discharged from acute medical wards. N Z Med J. 1975;81:508–12.

    CAS  PubMed  Google Scholar 

  31. Baekeland F, Lundwall L. Dropping out of treatment: a critical review. Psychol Bull. 1975;82:738–83.

    Article  CAS  PubMed  Google Scholar 

  32. Rosenstock IM. Patients’ compliance with health regimens. JAMA. 1975;234:402–3.

    Article  CAS  PubMed  Google Scholar 

  33. Stewart MA, McWhinney IR, Buck CW. The doctor/patient relationship and its effect upon outcome. J R College General Pract. 1979;29:77–82.

    CAS  Google Scholar 

  34. Mushlin AI, Appel FA. Diagnosing potential noncompliance. Arch Intern Med. 1977;137:318–21.

    Article  CAS  PubMed  Google Scholar 

  35. Deyo RA, Inui TS. Dropouts and broken appointments. A literature review and agenda for future research. Med Care. 1980;18:1146–57.

    Article  CAS  PubMed  Google Scholar 

  36. Greenberg RN. Overview of patient compliance with medication dosing: a literature review. Clin Ther. 1984;6:592–9.

    CAS  PubMed  Google Scholar 

  37. Luftey KE, Wishner WJ. Beyond “compliance is adherence”. Improving the prospect of diabetes care. Diabetes Care. 1999;22:635–9.

    Article  Google Scholar 

  38. Glasgow RE, Anderson RM. In diabetes care, moving from compliance to adherence is not enough. Something entirely different is needed. Diabetes Care. 1999;22:2090–2.

    Article  CAS  PubMed  Google Scholar 

  39. Dracup KA, Meleis AI. Compliance: an interactionist approach. Nurs Res. 1982;31:31–6.

    Article  CAS  PubMed  Google Scholar 

  40. Meichenbaum D, Turk DC. Facilitating treatment adherence: a practitioner’s guidebook. New York: Plenum Publishing Corp; 1987.

    Book  Google Scholar 

  41. Wright EC. Non-compliance – or how many aunts has Matilda? Lancet. 1993;342:909–13.

    Article  CAS  PubMed  Google Scholar 

  42. Urquhart J. Patient non-compliance with drug regimens: measurement, clinical correlates, economic impact. Eur Heart J. 1996;17:8–15.

    Article  PubMed  Google Scholar 

  43. Houston-Miller N, Hill M, Kottke T, Ockene IS. The multilevel challenge: recommendations for a call to action. A statement for healthcare professionals. Circulation. 1997;95:1085–90.

    Article  Google Scholar 

  44. World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.

    Google Scholar 

  45. Balkrishnan R. The importance of medication adherence in improving chronic disease related outcomes: what we know and what we need to further know. Med Care. 2005;43:517–20.

    Article  PubMed  Google Scholar 

  46. Steiner JF. Rethinking adherence. Ann Intern Med. 2012;157:580–5.

    Article  PubMed  Google Scholar 

  47. Cramer JA, Mattson RH, Prevey ML, Scheyer RD, Oulette VL. How often is medication taken as prescribed? A novel assessment technique. JAMA. 1989;261:3273–7.

    Article  CAS  PubMed  Google Scholar 

  48. Petchey R, Murphy E. Patient compliance. BMJ. 1992;305:1434–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  49. Aronson JK, Hardman M. Patient compliance. BMJ. 1992;305:1009–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  50. Stephenson BJ, Rowe BH, Haynes RB, Macharia WM, Leon G. Is this patient taking the treatment as prescribed? JAMA. 1993;269:2779–81.

    Article  CAS  PubMed  Google Scholar 

  51. Horwitz RI, Horwitz SM. Adherence to treatment and health outcomes. Arch Intern Med. 1993;153:1863–8.

    Article  CAS  PubMed  Google Scholar 

  52. Shepard DS, Moseley TAE. Mailed versus telephoned appointment reminders to reduce broken appointments in a hospital outpatient department. Med Care. 1976;14:268–73.

    Article  CAS  PubMed  Google Scholar 

  53. Gates SJ, Colborn K. Lowering appointment failures in a neighborhood health canter. Med Care. 1976;14:263–7.

    Article  CAS  PubMed  Google Scholar 

  54. Macharia WM, Leon G, Rowe BH, Stephenson BJ, Haynes RB. An overview of interventions to improve compliance with appointment keeping for medical services. JAMA. 1992;267:1813–7.

    Article  CAS  PubMed  Google Scholar 

  55. Blackwell B, Griffin B, Magill M, Bencze R. Teaching medical students about treatment compliance. J Med Educ. 1978;53:672–5.

    CAS  PubMed  Google Scholar 

  56. Bond WS, Hussar DA. Detection methods and strategies for improving medication compliance. AJPH. 1991;48:1978–88.

    CAS  Google Scholar 

  57. Clark C, Barnard K, Cummins E, Royle P, Waugh N, Aberdeen Health Technology Assessment Group. Self-monitoring of blood glucose in type 2 diabetes: systematic review. Health Technol Assess. 2010;14(12):1–140.

    PubMed  Google Scholar 

  58. McManus RJ, Wood S, Bray EP, Glasziou P, Hayen A, Heneghan C, Mant J, Padfield P, Potter JF, Hobbs FD. Self-monitoring in hypertension: a web-based survey of primary care physicians. J Hum Hypertens. 2014;28:123–7.

    Article  CAS  PubMed  Google Scholar 

  59. Butryn ML, Phelan S, Hill JO, Wing RR. Consistent self-monitoring of weight: a key component of successful weight loss maintenance. Obesity (Silver Spring). 2007;15(12):3091–6.

    Article  PubMed  Google Scholar 

  60. Heneghan C, Alonso-Coello P, Garcia-Alamino JM, Perera R, Meats E, Glasziou P. Self-monitoring of oral anticoagulation: a systematic review and meta-analysis. Lancet. 2006;367(9508):404–11.

    Article  CAS  PubMed  Google Scholar 

  61. Glasziou P, Irwig L, Mant D. Monitoring in chronic disease: a rational approach. BMJ. 2005;330:644–8.

    Article  PubMed  PubMed Central  Google Scholar 

  62. Roter DL, Hall JA, Merisca R, Nordstrom B, Cretin D, Svarstad B. Effectiveness of interventions to improve patient compliance. A meta-analysis. Med Care. 1998;36:1138–61.

    Article  CAS  PubMed  Google Scholar 

  63. Van Dulmen S, Sluijs E, van Dijk L, de Ridder D, Heerdink R, Bensing J. Patient adherence to medical treatment: a review of reviews. BMC Health Serv Res. 2007;7:1–13.

    Google Scholar 

  64. Viswanathan M, Golin CE, Jones CD, Ashok M, Blalock SJ, Wines RC, Coker-Schwimmer EJ, Rosen DL, Sista P, Lohr KN. Interventions to improve adherence to self-administered medications for chronic diseases in the United States: a systematic review. Ann Intern Med. 2012;157(11):785–95.

    Article  PubMed  Google Scholar 

  65. Haynes RB, McKibbon KA, Kanani R. Systematic review of randomized trials of interventions to assist patients to follow prescriptions for medications. Lancet. 1996;348:383–6.

    Article  CAS  PubMed  Google Scholar 

  66. Haynes RB, McKibbon KA, Brouwers MC, Oliver T. Interventions to assist patients to follow prescriptions for medications. Cochrane Libr. 1998;3:1–20.

    Google Scholar 

  67. McDonald HP, Garg AX, Haynes RB. Interventions to enhance patient adherence to medication prescriptions. Scientific review. JAMA. 2002;288:2868–79.

    Article  PubMed  Google Scholar 

  68. Nieuwlaat R, Wilczinski N, Navarro T, Hobson N, Jeffery R, Keepanasseril A, et al. Interventions for enhancing medication adherence. Cochrane Database Syst Rev. 2014;2014(11) Art. No. CD000011

    Google Scholar 

  69. Sackett DL. Why won’t hypertensive patients take their medicine? Can Fam Physician. 1977;23:72–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  70. Caldwell JR, Cobb S, Dowling MD, de Jongh D. The dropout problem in antihypertensive treatment. A pilot study of social and emotional factors influencing a patient’s ability to follow antihypertensive treatment. J Chronic Dis. 1970;22:579–92.

    Article  CAS  PubMed  Google Scholar 

  71. Finnerty FA Jr, Mattice EC, Finnerty FA 3rd. Hypertension in the inner city. Analysis of clinic dropouts. Circulation. 1973;47:73–5.

    Article  PubMed  Google Scholar 

  72. Finnerty FA. The problem of noncompliance in hypertension. Bull NY Acad Med. 1982;58:95–202.

    Google Scholar 

  73. Rudd P, Marton KI. Non-traditional problems of antihypertensive management. West J Med. 1979;131:179–92.

    CAS  PubMed  PubMed Central  Google Scholar 

  74. Rudd P. Clinicians and patients with hypertension: unsettled issues about compliance. Am Heart J. 1995;130:572–9.

    Article  CAS  PubMed  Google Scholar 

  75. Hill MN, Miller NH, DeGeest S. ASH position paper: adherence and persistence with taking medication to control high blood pressure. J Clin Hypertens. 2010;12:757–64.

    Article  Google Scholar 

  76. Milchack JL, Carter BL, James PA, Ardery G. Measuring adherence to practice guidelines for the Management of Hypertension. An evaluation of the literature. Hypertension. 2004;44:602–8.

    Article  Google Scholar 

  77. Vrijens B, Vincze G, Kristanto P, Urquhart J, Burnier M. Adherence to prescribed antihypertensive drug treatments: longitudinal study of electronically compiled dosing histories. BMJ. 2010;336:1114.

    Article  Google Scholar 

  78. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348–54.

    Article  Google Scholar 

  79. Korb-Savoldelli V, Gillaizeau F, Pouchot J, Lenain E, Postel-Vinay N, Plouin P-F, et al. Validation of a French version of the 8-item Morisky medication adherence scale in hypertensive adults. J Clin Hypertens. 2012;14:429–34.

    Article  Google Scholar 

  80. Lee GK, Wang HH, Liu KQ, Cheung Y, Morisky DE, Wong MC. Determinants of medication adherence to antihypertensive medications among a Chinese population using Morisky medication adherence scale. PLoS One. 2013;8:e62775.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  81. Lee WY, Ahn J, Kim JH, Hong YP, Hong SK, Kim YT, Lee SH, Morisky DE. Reliability and validity of a self-reported measure of medication adherence in patients with type 2 diabetes mellitus in Korea. J Int Med Res. 2013;41:1098.

    Article  PubMed  Google Scholar 

  82. Mülhauser I, Berger M. Patient education – evaluation of a complex intervention. Diabetologia. 2002;45:1723–33.

    Article  Google Scholar 

  83. Dunn SM, Turtle JR. The myth of the diabetic personality. Diabetes Care. 1981;4:640–6.

    Article  CAS  PubMed  Google Scholar 

  84. Watkins JD, Williams F, Martin DA, Hogan MD, Anderson E. A study of diabetic patients at home. AJPH. 1967;57:452–9.

    CAS  Google Scholar 

  85. Sulway M, Tupling H, Webb K, Harris G. New techniques for changing compliance in diabetes. Diabetes Care. 1980;3:108–11.

    Article  CAS  PubMed  Google Scholar 

  86. Anderson RM. The personal meaning of having diabetes: implications for patient behavior and education or kicking the bucket theory. Diabet Med. 1986;3:85–9.

    Article  CAS  PubMed  Google Scholar 

  87. Hampson SE, Glasgow RE, Toobert DJ. Personal models of diabetes and their relations to self-care activities. Health Psychol. 1990;9:632–46.

    Article  CAS  PubMed  Google Scholar 

  88. Bennett-Johnson S. Methodological issues in diabetes research. Measuring adherence. Diabetes Care. 1992;15:1658–67.

    Article  Google Scholar 

  89. Cramer JA. A systematic review of adherence with medications for diabetes. Diabetes Care. 2004;27:1218–24.

    Article  PubMed  Google Scholar 

  90. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with type 2 diabetes: a retrospective cohort study. Diabet Med. 2002;19:279–84.

    Article  CAS  PubMed  Google Scholar 

  91. Hernández-Ronquillo L, Téllez-Zenteno JF, Garduño-Espinoza J, González-Aceves E. Factors associated with therapy noncompliance in type 2 diabetes patients. Salud Pública Mex. 2003;45:191–7.

    Article  PubMed  Google Scholar 

  92. Lemstra M, Nwankwo C, Bird Y, Moraros J. Primary nonadherence to chronic disease medcations: a meta-analysis. Patient Prefer Adherence. 2018;12:721–31.

    Article  PubMed  PubMed Central  Google Scholar 

  93. Leichter SB. Making outpatient care of diabetes more efficient: Analyzing noncompliance. Clin Diabetes. 2005;23:187–90.

    Article  Google Scholar 

  94. Soule-Odegard P, Gray SL. Barriers to medication adherence in poorly controlled diabetes mellitus. Diabetes Educ. 2008;34:692–7.

    Article  Google Scholar 

  95. Schafer LC, Glasgow RE, McCaul KD, Dreher M. Adherence to IDDM regimens: relationship to psychosocial variables and metabolic control. Diabetes Care. 1983;6:493–8.

    Article  CAS  PubMed  Google Scholar 

  96. Ary DV, Toobert D, Wilson W, Glasgow RE. Patient perspective on factors contributing to non-adherence to diabetes regimen. Diabetes Care. 1986;9:168–72.

    Article  CAS  PubMed  Google Scholar 

  97. Rosenstock IM. Understanding and enhancing patient compliance with diabetic regimens. Diabetes Care. 1985;8:610–6.

    Article  CAS  PubMed  Google Scholar 

  98. Bush MA. Compliance, education, and diabetes control. Mt Sinai J Med. 1987;54:221–6.

    CAS  PubMed  Google Scholar 

  99. Iuga AO, McGuire. Adherence and health care costs. Risk management and healthcare. Policy. 2014;4:35–44.

    Google Scholar 

  100. Stolpe S, Kroes MA, Webb N, Wisniewski T. A systematic review of insulin adherence measures in patients with diabetes. J Manag Care Spec Pharm. 2016;22:1224–46.

    PubMed  Google Scholar 

  101. Anghel LA, Farcas AM, Oprean RN. An overview of the common methods used to measure treatment adherence. Med Pharm Rep. 2019;92:117–22.

    PubMed  PubMed Central  Google Scholar 

  102. Pednekar PP, Agh T, Malmenäs M, Raval AD, Bennett BM, Borah M, et al. Methods for measuring multiple medication adherence: a systematic review – report of the ISPOR medication adherence and persistence special interest group. Value Health. 2019;22:139–56.

    Article  PubMed  Google Scholar 

  103. Conway C, Kelechi T, Gregoski M. Measuring medication adherence among type 2 diabetes: an integrative review. J Nurs Meas. 2020;16:JNM-18-00091.

    Google Scholar 

  104. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15:728–40.

    PubMed  Google Scholar 

  105. Van Bruggen R, Gorter K, Stolk RP, Zuithoff P, Klungel OH, Rutten GEHM. Refill adherence and polypharmacy among patients with type 2 diabetes in general practice. Pharmacoepidemiol Drug Saf. 2009;18:983–91.

    Article  PubMed  Google Scholar 

  106. Fischer MA, Stedman MR, Lii J, Vogeli C, Shrank WH, Brookhart MA, et al. Primary medication non-adherence: analysis of 195,930 prescriptions. J Gen Intern Med. 2010;25:284–90.

    Article  PubMed  PubMed Central  Google Scholar 

  107. Koro CE, Chabra P, Stender M, Spain CV, Allen JK, Krzywy HJ. Treatment utilization of GLP-1 agonists and DPP-4 inhibitors among type 2 diabetics in a U.S. commercially insured population 2005–2011. Diabetes. 2013;62:A365–438.

    Google Scholar 

  108. Alfian SD, Sukandar H, Lestari K, Abdulah R. Medication adherence contributes to an improved quality of life in type 2 diabetes mellitus patients: a cross-sectional study. Diabetes Ther. 2016;7:755–64.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  109. Al-Keliani MS, Almomani BA, Al-Sawalha NA, Shhabat BA. Self-monotoring of blood glucose among patients in Jordan: perception, adherence and influential factors. Diabetes Res Clin Pract. 2017;126:79–85.

    Article  Google Scholar 

  110. He X, Chen L, Wang K, Wu H, Wu J. Insulin adherence among Chinese patients with type 2 diabetes: a retrospective database analysis. Patient Prefer Adherence. 2017;11:237–45.

    Article  PubMed  PubMed Central  Google Scholar 

  111. Lin J, Lingohr-Smith M, Fan T. Real-world medication persistence and outcomes associated with basal insulin and glucagon-like peptide I receptor agonist free-dose combination therapy in patients with type 2 diabetes in the US. ClinicoEconomics Outcomes Res. 2017;9:19–29.

    Article  Google Scholar 

  112. Flory J, Gerhard T, Stempniewicz N, Keating S, Rowan CG. Comparative adherence to diabetes drugs: an analysis of electronic health records and claims data. Diabetes Obes Metab. 2017;19:1184–7.

    Article  CAS  PubMed  Google Scholar 

  113. Alshehri KA, Altuwaylie TM, Alqhtani A, Albawab A, Almaiki AH. Type 2 diabetic patients adherence toward their medications. Cureus. 2020;12:a6932.

    Google Scholar 

  114. Romagnoli A, Santoleri F, Costantini A. Drug utilisation pattern over 3 years in the real-world treatment of type II diabetes. Int J Clin Pract. 2021;75:e14120.

    Article  CAS  PubMed  Google Scholar 

  115. Birnbaum Y, Ye Y, Bajaj M. Type 2 and cardiovascular disease: a metabolic overview of recent clinical trials. J Diabetes Complicat. 2017;31:291–4.

    Article  Google Scholar 

  116. Hamersky CM, Fridman M, Gamble CL. Injectable antihyperglycemic: a systematic review and critical analysis of the literature on adherence, persistence, and health outcomes. Diabetes Ther. 2019;10:865–90.

    Article  PubMed  PubMed Central  Google Scholar 

  117. Ofori-Asenso R, Sahle BW, Chin KL, Mazidi M, Ademi Z, De Bruin ML. Poor adherence and persistence to sodium glucosa co-transporter 2 inhibitors in real-world settings: evidence from a systematic review and meta-analysis. Diabetes Metab Res Rev. 2021;37:e3350.

    Article  CAS  PubMed  Google Scholar 

  118. Kosiborod M. Following the LEADER – why this and other recent trials signal a major paradigm in the management of type 2 diabetes. J Diabetes Complicat. 2017;31:517–9.

    Article  Google Scholar 

  119. Becker MH, Maiman LA. Socio-behavioral determinants of compliance with health and medical care recommendations. Med Care. 1975;13:10–24.

    Article  CAS  PubMed  Google Scholar 

  120. Becker MH, Maiman LA, Kirscht JP, Haefner DP, Drachman RH. The health belief model and prediction of dietary compliance: a field experiment. J Health Soc Behav. 1977;18:348–66.

    Article  CAS  PubMed  Google Scholar 

  121. Maiman LA, Becker MH. The health belief model: origins and correlates in psychological theory. Health Educ Monogr. 1974;2:336–53.

    Article  Google Scholar 

  122. Rosenstock IM. Historical origins of the health belief model. Health Educ Monogr. 1974;2:328–35.

    Article  Google Scholar 

  123. Delamater. Improving patient adherence. Clin Diabetes. 2006;24:71–7.

    Article  Google Scholar 

  124. Boyer BA, Lerman C, Shipley TE, McBrearty J, Goren E. Discordance between physician and patient perceptions in the treatment of diabetes mellitus: a pilot study of the relationship to adherence and glycemic control. Diabetes Educ. 1996;22:493–9.

    Article  CAS  PubMed  Google Scholar 

  125. Du Pasquier-Fediaevsky L, Tubiana-Rufi N. Discordance between physician and adolescent assessments of adherence to treatment. Influence of HbA1c level. Diabetes Care. 1999;22:1445–9.

    Article  PubMed  Google Scholar 

  126. De Figuereido RC, Snoek FJ, Barreto SM. Do patients and physicians agree on diabetes management? A study conducted in public health centers in Brazil. Patient Educ Couns. 2013;92:107–13.

    Article  Google Scholar 

  127. St H, Pollets D. Psychological aspects of diabetes mellitus: a critical review. Diabetes Care. 1979;2:227–32.

    Article  Google Scholar 

  128. ISPAD Clinical Practice Consensus Guidelines Compendium. Psychological care of children and adolescents with type 1 diabetes. Pediatr Diabetes. 2014;15(Suppl 20):232–44.

    Google Scholar 

  129. American Diabetes Association. Facilitating behavior change and well-being to improve health outcomes: standards of medical care in Diabetes 2021. Diabetes Care. 2021;44:S53–72.

    Article  Google Scholar 

  130. Robinson DJ, Coons M, Haensel H, Vallis M, Yale J. Diabetes and mental health. Can J Diabetes. 2018;42:S130–41.

    Article  PubMed  Google Scholar 

  131. Glasgow RE, Wilson W, McCaul KD. Regimen adherence: a problematic construct in diabetes research. Diabetes Care. 1985;8:300–1.

    Article  CAS  PubMed  Google Scholar 

  132. Glasgow RE. Psychological issues in diabetes. Diabetes Care. 1981;6:656–7.

    Google Scholar 

  133. Schafer LC, McCaul KD, Glasgow RE. Supportive and non-supportive family behaviors: relationships to adherence and metabolic control in persons with type 1 diabetes. Diabetes Care. 1986;9:179–85.

    Article  CAS  PubMed  Google Scholar 

  134. Wilson W, Ary DV, Biglan A, Glasgow RE, Toobert DJ, Campbell DR. Psychosocial predictors of self-care behaviors (compliance) and glycemic control in non-insulin-dependent diabetes mellitus. Diabetes Care. 1986;9:614–22.

    Article  CAS  PubMed  Google Scholar 

  135. Glasgow RE, Toobert DJ. Social environment and regimen adherence among type II diabetic patients. Diabetes Care. 1988;11:377–86.

    Article  CAS  PubMed  Google Scholar 

  136. Glasgow RE, McCaul KD, Schafer LC. Self-care behaviors and glycemic control in type 1 diabetes. J Chronic Dis. 1987;40:399–412.

    Article  CAS  PubMed  Google Scholar 

  137. Hampson SE, Glasgow RE, Foster LS. Personal models of diabetes among older adults: relationship to self-management and other variables. Diabetes Educ. 1995;21:300–7.

    Article  CAS  PubMed  Google Scholar 

  138. Glasgow RE, Hampson SE, Strycker LA, Ruggiero L. Personal-model beliefs and social-environmental barriers related to diabetes self-management. Diabetes Care. 1997;20:556–61.

    Article  CAS  PubMed  Google Scholar 

  139. Polonsky WH, Skinner TC. Perceived treatment efficacy: an overlooked opportunity in diabetes care. Clin Diabetes. 2010;28:89–92.

    Article  Google Scholar 

  140. Christie D, Channon S. The potential for motivational interviewing to improve outcomes in the management of diabetes and obesity in paediatric and adult populations: a clinical review. Diabetes Obes Metab. 2014;16:381–7.

    Article  CAS  PubMed  Google Scholar 

  141. Miller WR. Behavioral treatment of problem drinkers: a comparative outcome study of three controlled drinking therapies. J Consult Clin Psychol. 1978;46:74–86.

    Article  CAS  PubMed  Google Scholar 

  142. Bandura A. Self-efficacy: the exercise of control. New York: WH Freeman and Company; 1997.

    Google Scholar 

  143. Rollnick S, Butler CC, McCambridge J, Kinnersley P, Elwyn G, Resnicow K. Consultations about changing behavior. BMJ. 2005;331:961–3.

    Article  PubMed  PubMed Central  Google Scholar 

  144. Rollnick S, Butler CC, Kinnersley P, Gregory J, Mash B. Motivational interviewing. BMJ. 2010;340:1242–5.

    Article  Google Scholar 

  145. Miller WR, Rollnick S. Motivational interviewing. Preparing people for change. 2nd ed. New York: The Guilford Press; 2002.

    Google Scholar 

  146. Rollnick S, Miller WR, Butler CC. Motivational interviewing in health care: helping patients change behavior. New York: The Guilford Press; 2008.

    Google Scholar 

  147. Doherty Y, Roberts S. Motivational interviewing in diabetes practice. Diabet Med. 2002;19:1–6.

    Article  PubMed  Google Scholar 

  148. Pladevall M, Divine G, Wells KE, Resnocow K, Williams LK. A randomized controlled trial to provide adherence information and motivational interviewing to improve diabetes and lipid control. Diabetes Educ. 2015;41:136–46.

    Article  PubMed  Google Scholar 

  149. Ekong G, Kavookjian J. Motivational interviewing and outcomes in adults with type 2 diabetes: a systematic review. Patient Educ Couns. 2016;99:944–52.

    Article  PubMed  Google Scholar 

  150. Anderson RM. Patient empowerment and the traditional medical model. A case of irreconcilable differences? Diabetes Care. 1995;18:412–5.

    Article  CAS  PubMed  Google Scholar 

  151. Anderson RM, Funnell MM. Compliance and adherence are dysfunctional concepts in diabetes care. Diabetes Educ. 2000;26:597–604.

    Article  CAS  PubMed  Google Scholar 

  152. Garattini L, Padula A. Patient empowerment in Europe: is no further research needed? Eur J Health Econ. 2018;19:637–40.

    Article  PubMed  Google Scholar 

  153. Anderson RM, Funnell MM, Barr PA, Dedrick RF, Davis WK. Learning to empower patients. Results of professional education program for diabetes educators. Diabetes Care. 1991;14:584–90.

    Article  CAS  PubMed  Google Scholar 

  154. Feste C, Anderson RM. Empowerment: from philosophy to practice. Patient Educ Couns. 1995;26:139–44.

    Article  CAS  PubMed  Google Scholar 

  155. Funnell MM, Anderson RM, Arnold MS, Barr PA, Donnelly M, Johnson PD, Taylor-Moon D, White NH. Empowerment: an idea whose time has come in diabetes education. Diabetes Educ. 1991;17:37–41.

    Article  CAS  PubMed  Google Scholar 

  156. Anderson RM, Funnell MM. The art of empowerment. Stories and strategies for diabetes educators. Alexandria, VA: American Diabetes Association; 2000.

    Google Scholar 

  157. Anderson RM, Funnell MM. Patient empowerment: myths and misconceptions. Patient Educ Couns. 2010;79:277–82.

    Article  PubMed  Google Scholar 

  158. Hernandez-Tejada MA, Campbell JA, Walker RJ, Smalls BL, Davis KS, Egede LE. Diabetes empowerment, medication adherence and self-care behaviors in adults with type 2 diabetes. Diabetes Technol Ther. 2012;14:630–4.

    Article  PubMed  PubMed Central  Google Scholar 

  159. Luftey KE, Ketchman JD. Patient and provider assessments of adherence and the sources of disparities: evidence from diabetes care. Health Serv Res. 2005;40:1803–17.

    Article  Google Scholar 

  160. Littenberg B, Mac Lean CD, Hurowitz L. The use of adherence aids by adults with diabetes: a cross sectional survey. BMC Fam Pract. 2006;7:1–5.

    Article  PubMed  PubMed Central  Google Scholar 

  161. Puder JJ, Keller U. Quality of diabetes care: problem of patient or doctor adherence? Swiss Med Wkly. 2003;133:530–4.

    PubMed  Google Scholar 

  162. Samuels TA, Bolen S, Yeh HC, Abuid M, Marinoupoulos SS, Weiner JP, et al. Missed opportunities in diabetes management: a longitudinal assessment of factors associated with sub-optimal quality. J Gen Intern Med. 2008;23:1770–7.

    Article  PubMed  PubMed Central  Google Scholar 

  163. Schmittdiel JA, Uratsu CS, Karter AJ, Heisler M, Subramanian U, Mangione CM, Selby JV. Why don’t patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification. J Gen Intern Med. 2008;23:588–94.

    Article  PubMed  PubMed Central  Google Scholar 

  164. Miller TA, DiMatteo MR. Importance of family/social support and impact on adherence to diabetic therapy. Diabetes Met Synd Obes. 2013;6:421–6.

    Article  Google Scholar 

  165. Del Canale S, Louis DZ, Maio V, Wang X, Rossi G, Hojat M, Gonella JS. The relationship between physician empathy and disease complications: an empirical study of primary care physicians and their diabetic patients in Parma, Italy. Acad Med. 2012;87:1243–9.

    Article  PubMed  Google Scholar 

  166. Beaser RS, Brown JA. Preventive intervention in diabetes: a new model for continuing medical education. Am J Prev Med. 2013;44:S394–9.

    Article  PubMed  Google Scholar 

  167. Ingelfinger FJ. Arrogance. N Engl J Med. 1980;303:1507–11.

    Article  CAS  PubMed  Google Scholar 

  168. Romano PE. Semantics: compliance is a better term than cooperation. Arch Ophtalmol. 1987;105:314–5.

    Article  CAS  Google Scholar 

  169. Steiner JF, Earnest MA. The language of medication-taking. Ann Intern Med. 2000;132:926–30.

    Article  CAS  PubMed  Google Scholar 

  170. Kleisinger F. The unmet challenge of medication nonadherence. Perm J. 2018;22:18–033.

    Google Scholar 

  171. Guerci B, Chanan N, Kaur S, Jasso-Mosqueda JG. Lack of treatment persistence and treatment nonadherence as barriers to glycaemic control in patients with type 2 diabetes. Diabetes Ther. 2019;10:437–49.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Multidisciplinary Centre of Diabetes, Mexico City, Mexico

    Joel Rodriguez-Saldana

Authors
  1. Joel Rodriguez-Saldana
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Mexico City, Mexico

    Joel Rodriguez-Saldana

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Rodriguez-Saldana, J. (2023). Patient Adherence: Challenges, Myths, and Realities. In: Rodriguez-Saldana, J. (eds) The Diabetes Textbook. Springer, Cham. https://doi.org/10.1007/978-3-031-25519-9_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-25519-9_27

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-25518-2

  • Online ISBN: 978-3-031-25519-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation